PETALING JAYA: The Malaysian Pharmacists Society (MPS) has expressed concern about the delayed progression of the Control of Smoking Products for Public Health Bill 2023. Despite the initial fanfare, the bill has not been given the attention necessary to address the public health crisis it is designed to prevent. MPS issued a statement on November 7th, noting the apparent lack of commitment from the government to pass the bill in Parliament. The society believes that there is no political will to advance this bill urgently and with the seriousness it deserves.
In its statement, MPS highlights the devastating health implications of continued inaction and the impact it will have on future health expenditure. The society is deeply disappointed by the lack of effort to address the public health crisis adequately. MPS argues that it has become increasingly evident to the people, health professionals, and concerned parents that the government is not prioritizing the bill.
The MPS statement also emphasizes the urgent need for action to address the public health crisis caused by smoking. The society believes that the government’s failure to take decisive action is detrimental to the well-being of the population, particularly young people who are susceptible to the harmful effects of smoking. The bill is intended to protect public health and reduce the burden of smoking-related diseases.
For the full statement from the Malaysian Pharmacists Society, click here.
